ARISTEIA CAPITAL, L.L.C. - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 58 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
ARISTEIA CAPITAL, L.L.C. ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q2 2019$3,678,000
-87.0%
4,000,000
-86.9%
0.17%
-88.9%
Q1 2019$28,271,000
+916.2%
30,500,000
+916.7%
1.54%
+1488.7%
Q2 2018$2,782,000
-21.1%
3,000,000
-25.0%
0.10%
-30.7%
Q1 2018$3,527,000
-78.4%
4,000,000
-78.4%
0.14%
-79.9%
Q4 2017$16,361,00018,500,0000.70%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q2 2018
NameSharesValueWeighting ↓
Western Asset Management Company, LLC 18,321,000$16,718,0009.03%
INCOME RESEARCH & MANAGEMENT 15,589,000$14,000,0006.80%
WHITEBOX ADVISORS LLC 16,000,000$14,487,0000.53%
Graham Capital Management, L.P. 16,525,000$15,005,0000.49%
ONTARIO TEACHERS PENSION PLAN BOARD 18,400,000$16,752,0000.30%
WESTWOOD HOLDINGS GROUP INC 29,005,000$26,516,0000.29%
Penn Capital Management Company, LLC 2,195,000$1,987,0000.21%
ADVENT CAPITAL MANAGEMENT /DE/ 10,000,000$9,128,0000.17%
Polar Capital LLP 20,663,000$18,813,0000.17%
RIVERHEAD CAPITAL MANAGEMENT LLC 5,000,000$4,529,0000.17%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders